15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation
about
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysisInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsDoes the use of acetylsalicylic acid have an influence on our vision?Platelets in inflammation and atherogenesisNew insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxinsNew signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells"Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersRoles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunctionResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsChronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recoveringThe lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humansEvidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisA randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humansSpecialized pro-resolving lipid mediators in the inflammatory response: An updateInflammation and its resolution as determinants of acute coronary syndromes.Short-term physical inactivity impairs vascular function.Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationNitric oxide is negatively correlated to pain during acute inflammation.Proresolving lipid mediators and mechanisms in the resolution of acute inflammationEndogenous lipid mediators in the resolution of airway inflammationHistone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsTransgenic mice rich in endogenous omega-3 fatty acids are protected from colitisMechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.Consistent inhibition of cyclooxygenase drives macrophages towards the inflammatory phenotypeA role for lipoxin A₄ as an anti-inflammatory mediator in the human endometriumLovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brainAssociation between aspirin therapy and the outcome in critically ill patients: a nested cohort studyLipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells.Controlling inflammation: a fat chance?Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6.Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study.
P2860
Q22241651-228238DC-16CC-4159-B234-7109E1C65663Q24652940-E029E560-57A6-483D-B3D6-C33E331558B6Q27014988-B8B14508-59E2-48CA-805F-97FAF22B044DQ28066055-3C364D43-7DF1-4458-8909-C4408F04B9E2Q28085020-1DD28D61-3518-4845-947C-653C613EA18BQ28180867-0CFF112B-F6BC-4C0F-A1A1-B44E9CD67501Q28187259-337266F2-24FD-4E46-A436-FAAD122EC7CCQ28200449-FC0A2935-EE99-44C5-BDBE-AD684D6BB510Q28222594-880BEE35-8094-4125-91E4-AF867EB9FD68Q29615694-64591AE2-F6AC-4216-AB26-61B1446F5D27Q30415505-14BFFDE8-6C9F-4035-946B-EC3DA9D3DE79Q30495582-40EC3607-796B-4633-A963-FC1A1BECFA2DQ30504456-E9B808A3-2AF2-4006-9630-5B2727FED963Q31134484-010F3095-BD8C-4023-B658-E8B2CF4E417CQ33513370-2D6FEA26-4CBB-43D0-996E-1A73066BC3E7Q33582804-82039AEF-49E7-4BA1-A339-12419F4626FFQ33657562-4B58A7D0-5677-44F7-8DDC-657B1C31B908Q33834800-A4387C32-F326-4F06-9165-6F965A42F1C4Q33896015-5C002685-63E7-4CC3-834D-E8B5C7BDF462Q33928544-4E987BAF-959A-4EED-832B-5DDCE2D82147Q34157528-D9C54FF9-1693-4512-A8DD-EFEE23C5ED46Q34173909-878DE169-F6DC-4698-970F-D475EF5BEB06Q34411426-AD66128F-E66E-48BD-9D11-444F79D49FF6Q34423359-587867B5-D339-44A2-B023-16B055A1DBE9Q34514079-CCB5E596-2347-48BC-88F0-100C295A8E04Q34522097-9AC66DEB-312D-4972-A043-639C9A3DFBC5Q34645842-E7BE8F8B-2BEC-4EA9-A428-D0DDD8938417Q34983954-CB513A53-DB6E-4965-9BB6-C89CB62A4579Q35005089-BD1E4B2F-477D-4CC8-BE09-5560711D8897Q35101603-BB25BDF8-372F-4D3A-8EB7-CDDFA7DB6CF3Q35114951-816BDCAF-E4DF-49BC-8698-6E82BC23DEB2Q35679301-4507CA74-3545-4F1E-AE90-2ABCF40592C2Q35880859-E523E14F-4A90-4668-A445-520340F1244DQ35916354-A5CD9E96-7FEC-4EBC-87F2-6302B1E49C3AQ35919112-DEBE4806-5DAB-4072-B674-2202C6B033C9Q36064465-81C6F0DD-777E-48C6-AD79-A97CB222611AQ36141602-B1B76443-907B-4476-9F93-A47DA4F34207Q36549032-60445C8C-1C21-4F16-B8A8-FE4F2B08C78DQ36639986-852DA77A-33D0-47D9-B5C3-0D92A59CD111Q36663432-75D84890-8A6E-495B-AC8D-004C4390E8CA
P2860
15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@ast
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@en
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@nl
type
label
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@ast
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@en
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@nl
prefLabel
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@ast
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@en
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@nl
P2093
P2860
P3181
P356
P1476
15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation
@en
P2093
Dianne Cooper
Mark J Paul-Clark
Niloufar Moradi-Bidhendi
Thong Van Cao
P2860
P3181
P356
10.1084/JEM.20040566
P407
P577
2004-07-05T00:00:00Z